Amino acid position 123 in the E protein of Japanese encephalitis virus (JEV) determines viral growth properties and pathogenicity. The majority of JEV strains have a serine residue at this position (E 123S ); however, JEV with an asparagine residue (E 123N ) has also been isolated. To compare the growth properties and pathogenicity of E 123S and E 123N JEV, we produced recombinant JEV with a serine-to-asparagine substitution at position 123 (rJEV-Mie41-E S123N ) in the E 123S -type strain Mie/41/2002 background. The growth rate of rJEV-Mie41-E S123N was similar to that of Mie/41/2002 in mammalian and mosquito cell lines. Mouse challenge experiments showed that there was only a slight difference in neuroinvasiveness between the parent strain (Mie/41/2002) and rJEV-Mie41-E S123N . Thus, our results indicate that the Ser-toAsn substitution in the JEV E protein has weak impact on viral growth properties in vitro or on pathogenicity in vivo.
Japanese encephalitis virus (JEV), which belongs to the genus Flavivirus of the family Flaviviridae, is a mosquitoborne flavivirus that causes severe encephalitis in humans. Japanese encephalitis (JE) is the most important cause of epidemic viral encephalitis in many Asian countries. The case fatality rate of JE is approximately 30 %, and about 30 000-50 000 clinical cases of JE and 10 000 deaths are reported annually, mainly in China, South-east Asian countries and India (Tsai, 2000) . In recent decades, cases of JE have also been reported in northern areas of Australia (Hanna et al., 1996) . JEV strains are now classified into five genotypes (genotypes I-V) on the basis of genomic RNA homology (Uchil & Satchidanandam, 2001; Solomon et al., 2003) . In the early 1990s, the genotype of JEV most frequently isolated in Japan changed from genotype III to genotype I (Ma et al., 2003; Yoshida et al., 2005; Nerome et al., 2007) . A similar shift from genotype III to genotype I has also been demonstrated in other East, South-east and South Asian countries (Nam et al., 1996; Nga et al., 2004; Yang et al., 2004; Wang et al., 2007; Nitatpattana et al., 2008; Yun et al., 2010; Chen et al., 2011; Fulmali et al., 2011; Pan et al., 2011; Zhang et al., 2011) .
JEV has a single-stranded and positive-sense RNA genome approximately 11 kb in length, which encodes three structural proteins [capsid (C), premembrane (prM) and envelope (E)] and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) in one open reading frame. The E protein is the main surface structural protein and consists of three domains (domains I-III) (Rey et al., 1995) . This protein is thought to play a major role in determining viral pathogenicity by defining cell tropism and mediating entry into susceptible cells (Gubler et al., 2007; Lindenbach et al., 2007) . Since the early 1990s, several attempts to elucidate the molecular mechanisms of JEV virulence have been carried out by comparing the nucleotide sequences of virus strains with varying degrees of virulence. Some of these reports have indicated that nucleotide substitutions in the E protein may alter the virulence of JEV (Nitayaphan et al., 1990; Aihara et al., 1991; Cecilia & Gould, 1991; Hasegawa et al., 1992; Sumiyoshi et al., 1995; Chen et al., 1996; Ni & Barrett, 1996 , 1998 Arroyo et al., 2001; Wu et al., 2003; Lee et al., 2004; Chambers et al., 2007; Pujhari et al., 2010; Wu et al., 2011) . Studies using an infectious clone of JEV demonstrated that a single glutamic acid-to-lysine mutation at position 138 in the E protein attenuated the parent JEV strain (Sumiyoshi et al., 1995; Zhao et al., 2005; Liang et al., 2009) . Furthermore, a single methionine-to-lysine mutation at position 279 in the E protein of a JEV/yellow fever virus chimera increased virulence in mice (Monath et al., 2002) . Recently, we reported that the amino acid at position 123 of the E protein determines the growth properties and pathogenicity of JEV (Tajima et al., 2010) . Amino acids 123 and 279 are located in domain II, whereas amino acid 138 is located in domain I. Domain II is important for homodimerization of the E protein, and amino acid mutations in domain II are thought to influence virulence by affecting low pH conformational transitions (Rey et al., 1995; Kolaskar & Kulkarni-Kale, 1999; Nybakken et al., 2006) . Domain I is located between domains II and III and acts as a hinge region, providing flexibility to the structural E protein (Rey et al., 1995; Zhao et al., 2005) .
JEV strains with a serine residue at position 123 of the E protein (E 123S ) represent the majority of genotype I strains isolated thus far. In contrast, JEV strains with an arginine residue at position 123 of the E protein (E 123R ), e.g. Beijing-1, a high-passage genotype III strain (GenBank accession no. AB510530) used in our previous study, form a small minority group, and an E 123R strain has not been identified in the genotype I group (Tajima et al., 2010) . Recently, two genotype I strains with an asparagine residue at position 123 (E 123N ) were obtained from paediatric JE patients in China . In Japan, we also identified two of 22 isolates as genotype I with the E 123N mutation from pig serum and mosquito pool ( Fig. 1 and Table S1 , available in JGV Online). Phylogenetic analysis of the whole E nucleotide sequence of 49 genotype I strains isolated in Japan, China, Taiwan, South Korea and Vietnam showed that most E 123N strains form a cluster group among genotype I (Fig. 1) . We previously showed that E 123R strains exhibit an increased growth rate in mouse neuroblastoma N18 cells and augmented pathogenicity in mice (Tajima et al., 2010) . However, the properties of E 123N strains in vitro and in vivo remain unknown.
To gain insight into the nature of E 123N JEV strains, we generated a recombinant JEV clone with a single Ser-toAsn substitution at position 123 of the E protein (E S123N ) in the Mie/41/2002 background, namely, rJEV-Mie41-E S123N , and a recombinant virus with an E S123R substitution, rJEV-Mie41-E S123R (Tajima et al., 2010) (Fig. 2a) . The recombinant viruses were recovered by transfection of in vitro-transcribed recombinant viral RNA into Vero cells, as previously described (Tajima et al., 2010) . Thereafter, we examined the growth properties of rJEV-Mie41-E S123N and rJEV-Mie41-E S123R (as well as those of the parental strain, Mie/41/2002, as a control) in four cell lines: Vero, porcine kidney PK-15, mouse neuroblastoma N18 and mosquito C6/36 cells. The plaque sizes of the three JEV strains were compared in Vero cells, as previously reported (Yamaguchi et al., 2011) . The plaques induced by rJEV-Mie41-E S123R in Vero cells were smaller than those induced by Mie/41/2002 (Tajima et al., 2010) , whereas the plaques induced by rJEVMie41-E S123N were similar in size to those of Mie/41/2002 (Fig. 2b) . We next compared the growth of the three strains at an m.o.i. of 0.01 in the four cell lines, as previously described (Tajima et al., 2010; Yamaguchi et al., 2011) . The growth curves in Vero and PK-15 cells were very similar for all three strains (Fig. 2c, d ). Our previous report demonstrated that the growth characteristics of E 123R strains in N18 cells were positively correlated with neuroinvasiveness in mice (Tajima et al., 2010) . While the growth curve of rJEV-Mie41-E S123N was similar to that of Mie/41/2002 in N18 cells, the growth of rJEV-Mie41-E S123R was more rapid than either of these strains (Fig. 2e) . Thus, this result suggested that the S123N substitution in the JEV E protein might not affect its neuroinvasiveness in mice. In C6/36 cells, the growth rate of rJEV-Mie41-E S123N was similar to that of Mie/41/2002, while the growth rate of rJEV-Mie41-E S123R was significantly lower than that of the Mie/41/2002 (Fig. 2f) .
To determine whether the S123N substitution altered neuroinvasiveness in vivo, groups of 3-week-old female ddY mice were infected intraperitoneally with Mie/41/ 2002, rJEV-Mie41-E S123N or rJEV-Mie41-E S123R at a dose of 1610 5 or 1610 3 p.f.u. and observed for 3 weeks (Table  1) . Mouse challenge experiments were performed in accordance with the Guidelines for animal experiments performed at the National Institute of Infectious Diseases by the Animal Welfare and Animal Care Committee of the National Institute of Infectious Diseases, Japan. In experiment 1 (1610 5 p.f.u.), 10/10 (100 %) and 7/10 (70 %) mice infected with rJEV-Mie41-E S123R and rJEVMie41-E S123N , respectively, died within 2 weeks of the challenge, whereas only two (20 %) mice infected with Mie/ 41/2002 died during the observation period. However, just 2/12 (16.7 %) mice infected with rJEV-Mie41-E S123N died during the observation period in experiment 3 (1610 5 p.f.u.). No apparent difference in virulence was observed among viruses in the low-dose group (experiment 2; 1610 3 p.f.u.). To evaluate the neurovirulence of the viruses in mice, groups of mice were infected intracerebrally with the three viruses at a dose of 1610 3 or 1610 p.f.u. and observed for 3 weeks (Table 1 , experiments 4 and 5). In contrast with the results of intraperitoneal infection, all three viruses displayed similar survival patterns at both doses. We determined the nucleotide sequence of the JEV E region (1500 nt) from the brain samples of 15 dead mice infected with JEV, and it was confirmed that the amino acid sequence at position 123 of the E protein was retained, and no additional mutations were observed in the E region (data not shown).
The E protein of flavivirus is thought to be critical for viral pathogenicity. Our previous report demonstrated that an S123R substitution in the JEV E protein increases the pathogenicity of JEV in mice (Tajima et al., 2010) . However, E 123R JEV represents a small minority of the JEV strains registered in GenBank (data not shown), suggesting that this strain of JEV may rarely circulate in nature. In recent years, most of the JEV strains isolated in nature have been E
123S
-and E 123N -type viruses. Thus, the effect of the S123N substitution in the E protein on the growth and pathogenicity of JEV was analysed in the present study. The growth kinetics of the recombinant rJEV-Mie41-E S123N strain were similar to those of the parent E 123S strain (Mie/41/2002) in Vero and PK15 cells. rJEV-Mie41-E S123N virus showed higher neuroinvasiveness than Mie/41/2002 in one mouse challenge experiment; however, this result was not reproducible in other experiments. Furthermore, rJEV-Mie41-E S123N also showed similar neurovirulence to Mie/41/2002. Therefore, we concluded that there are only modest differences in growth in mammalian cells or pathogenicity in mice between Mie/ 41/2002 and rJEV-Mie41-E S123N . These results indicate that the Ser-to-Asn substitution of JEV E protein has weak impact on the growth properties of JEV in mammalian cells or on its virulence in mice.
rJEV-Mie41-E S123R JEV exhibited significantly lower growth rates in C6/36 cells and equivalent rates in mammalian kidney Vero and PK15 cells; it clearly displayed higher growth rates in mouse neuroblastoma N18 cells leading us to hypothesize that E 123R JEV adapts to mammalian nerve cells (Tajima et al., 2010) . The neurovirulence of the rJEV-Mie41-E S123R virus in mice was similar to that of Mie/41/2002 and rJEV-Mie41-E S123N viruses; however, the neuroinvasiveness of the rJEV-Mie41-E S123R virus was significantly higher than that of Mie/41/ 2002 and rJEV-Mie41-E S123N viruses. These observations indicate that the growth properties of JEV in N18 cells may reflect its neuroinvasiveness rather than its neurovirulence. The neuroinvasiveness analysis assesses the ability of the virus to not only induce damage to the brain but also replicate in peripheral tissues and invade the central nervous system. Thus, the S123R substitution could increase the ability of JEV to invade the central nervous system rather than the replication efficiency of JEV in the brain. The JEV E protein has a putative receptor-binding domain and plays a major role in penetration of susceptible cells. The amino acid at position 123 of the E protein is located in domain II, which is important not only for homodimerization but also for low pH conformational conversion to the fusogenic form (Rey et al., 1995; Kolaskar & Kulkarni-Kale, 1999; Nybakken et al., 2006) . These findings suggest that a mutation at position 123 of the JEV E protein -especially that of the neutral amino acid Ser to the basic amino acid Arg -may alter the critical pH required for conformational change prior to fusion 
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between the E protein and the endosome membrane within infected cells.
Recently, the crystal structure of the JEV E protein was determined (Luca et al., 2012) . The structural data demonstrated that amino acid 123 is located on the outer surface of JEV virions and does not directly contribute to dimer contacts (Fig. S1a, b) . The physical properties of the side chains of Ser, Asn and Arg are different, and molecular modelling analysis of the JEV E protein shows that an amino acid substitution at position 123, particularly S123R, may change the surface structure of the E protein ( Fig. S1c-e) . Therefore, as domain III of the flavivirus E protein appears to be involved in receptor binding, the S123R substitution might alter the affinity of the E protein for the surface molecule that is specifically expressed on the target cells and is required for attachment of JEV (Lee et al., 2004) . Since the early 1990s, the major genotype of JEV has gradually changed from III to I in most JEV-endemic areas. Most of the genotype I isolates are from mosquitoes and pig sera, and genotype I is less associated with human disease than genotype III. However, we detected genotype I genomes in the cerebrospinal fluid (CSF) of two meningitis patients (Kuwayama et al., 2005) . Moreover, genotype I strains were recently isolated from the CSF samples of human JE patients in China, confirming that genotype I JEV causes encephalitis in humans (Pan et al., 2011; Zhang et al., 2011) . The amino acid at position 123 of the E protein was Asn or Ser in a total of two and one isolates, respectively . In addition, three genotype I strains were isolated from the CSF of JE patients in India, and the amino acid at position 123 of the E protein was Ser in all three isolates (Fulmali et al., 2011) . Thus, both E 123S and E 123N JEV have been found in JE patients. However, the difference in pathogenicity between E 123S and E 123N JEV in humans remains unknown, and it is important to be vigilant for epidemics of JEV in nature.
